{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:22:50Z","timestamp":1791177770426,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MRC\/UVRI and LSHTM Uganda Research Unit and Makerere University Research and Innovations Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00771-y","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:51:26Z","timestamp":1762519886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A quadral biosignature of IFN-\u03b3, IL-2, IL-12 and IP-10 increases the diagnostic potential for latent tuberculosis among diabetic patients in Uganda"],"prefix":"10.1186","volume":"26","author":[{"given":"Phillip","family":"Ssekamatte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sitenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Nabatanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Nakibuule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Kibirige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Peter","family":"Kyazze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Patrick","family":"Kateete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Ssentalo","family":"Bagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obondo James","family":"Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Andia","family":"Biraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"771_CR1","doi-asserted-by":"crossref","unstructured":"Liu Q, Yan W, Liu R, Bo E, Liu J, Liu M. The association between diabetes mellitus and the risk of latent tuberculosis infection: A systematic review and Meta-Analysis. Front Med. 2022;9:8998214.","DOI":"10.3389\/fmed.2022.899821"},{"issue":"11","key":"771_CR2","doi-asserted-by":"publisher","first-page":"e0187967","DOI":"10.1371\/journal.pone.0187967","volume":"12","author":"RH Al-Rifai","year":"2017","unstructured":"Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2017;12(11):e0187967.","journal-title":"PLoS ONE"},{"issue":"4","key":"771_CR3","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S2214-109X(18)30487-X","volume":"7","author":"JJ Noubiap","year":"2019","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2\u00b73 million patients with tuberculosis. Lancet Global Health. 2019;7(4):e448\u201360.","journal-title":"Lancet Global Health"},{"key":"771_CR4","doi-asserted-by":"crossref","unstructured":"Boom WH, Schaible UE, Achkar JM. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Investig. 2021;131(3):e13622216.","DOI":"10.1172\/JCI136222"},{"key":"771_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","volume":"122","author":"C Ding","year":"2022","unstructured":"Ding C, Hu M, Guo W, Hu W, Li X, Wang S, et al. Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990\u20132019. Int J Infect Dis. 2022;122:46\u201362.","journal-title":"Int J Infect Dis"},{"issue":"3 3","key":"771_CR6","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","volume":"54 54","author":"A Cohen","year":"2019","unstructured":"Cohen A, Mathiasen VD, Sch\u00f6n T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54 54(3 3):1900655.","journal-title":"Eur Respir J"},{"issue":"9","key":"771_CR7","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S1473-3099(22)00153-0","volume":"22","author":"DW Dowdy","year":"2022","unstructured":"Dowdy DW, Behr MA. Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings? Lancet Infect Dis. 2022;22(9):e271\u20138.","journal-title":"Lancet Infect Dis"},{"key":"771_CR8","doi-asserted-by":"publisher","first-page":"l5770","DOI":"10.1136\/bmj.l5770","volume":"367","author":"MA Behr","year":"2019","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019;367:l5770.","journal-title":"BMJ"},{"key":"771_CR9","doi-asserted-by":"publisher","first-page":"1122255","DOI":"10.3389\/fimmu.2023.1122255","volume":"14","author":"P Ssekamatte","year":"2023","unstructured":"Ssekamatte P, Sande OJ, van Crevel R, Biraro IA. Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front Immunol. 2023;14:1122255.","journal-title":"Front Immunol"},{"key":"771_CR10","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization; 2018."},{"issue":"1","key":"771_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Therapy. 2024;9(1):262.","journal-title":"Signal Transduct Target Therapy"},{"key":"771_CR12","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 11th Edition. Brussels; 2025."},{"issue":"5","key":"771_CR13","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3390\/ijerph18052439","volume":"18","author":"B Stubbs","year":"2021","unstructured":"Stubbs B, Siddiqi K, Elsey H, Siddiqi N, Ma R, Romano E, et al. Tuberculosis and Non-Communicable disease multimorbidity: an analysis of the world health survey in 48 Low- and Middle-Income countries. Int J Environ Res Public Health. 2021;18(5):2439.","journal-title":"Int J Environ Res Public Health"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"771_CR15","doi-asserted-by":"publisher","first-page":"e0175925","DOI":"10.1371\/journal.pone.0175925","volume":"12","author":"MH Workneh","year":"2017","unstructured":"Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS ONE. 2017;12(4):e0175925.","journal-title":"PLoS ONE"},{"key":"771_CR16","doi-asserted-by":"crossref","unstructured":"Ssekamatte P, Nabatanzi R, Sitenda D, Nakibuule M, Bagaya BS, Kibirige D et al. Impaired Mycobacterium tuberculosis-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda. Front Immunol. 2024;15:148073929.","DOI":"10.3389\/fimmu.2024.1480739"},{"issue":"2","key":"771_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/eji.201545973","volume":"46","author":"NP Kumar","year":"2016","unstructured":"Kumar NP, Moideen K, George PJ, Dolla C, Kumaran P, Babu S. Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-\u03b2-dependent manner. Eur J Immunol. 2016;46(2):390\u20139.","journal-title":"Eur J Immunol"},{"key":"771_CR18","doi-asserted-by":"publisher","unstructured":"Ssekamatte P, Sitenda D, Nabatanzi R, Nkurunungi G, Nakibuule M, Kibirige D, et al. Metabolic dysfunction impairs Mycobacterium tuberculosis-specific cytokine and chemokine responses in latent tuberculosis and type 2 diabetes mellitus. Sci Rep. 2025;15(1):30474. https:\/\/doi.org\/10.1038\/s41598-025-16385-8.","DOI":"10.1038\/s41598-025-16385-8"},{"key":"771_CR19","doi-asserted-by":"crossref","unstructured":"Domingo-Gonzalez R, Prince O, Cooper A, Khader SA. Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiology Spectrum. 2016;4(5):4.5.23.","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016"},{"key":"771_CR20","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. World Health Organization; 2020."},{"issue":"1","key":"771_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10096-020-03997-3","volume":"40","author":"T Meier","year":"2021","unstructured":"Meier T, Enders M. High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing. Eur J Clin Microbiol Infect Dis. 2021;40(1):85\u201393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"771_CR22","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB gold plus performance in contact screening. Eur Respir J. 2016;48(5):1411\u20139.","journal-title":"Eur Respir J"},{"issue":"5","key":"771_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5588\/ijtld.14.0553","volume":"19","author":"JC Choi","year":"2015","unstructured":"Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH, Higashi J, Hopewell PC, et al. Reduced sensitivity of the QuantiFERON(\u00ae) test in diabetic patients with smear-negative tuberculosis. Int J Tuberc Lung Dis. 2015;19(5):582\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"771_CR24","doi-asserted-by":"publisher","first-page":"e0188631","DOI":"10.1371\/journal.pone.0188631","volume":"12","author":"TN Doan","year":"2017","unstructured":"Doan TN, Eisen DP, Rose MT, Slack A, Stearnes G, McBryde ES. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis. PLoS ONE. 2017;12(11):e0188631.","journal-title":"PLoS ONE"},{"issue":"7","key":"771_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/07853890.2020.1800073","volume":"52","author":"X Qiu","year":"2020","unstructured":"Qiu X, Huiqing W, Ying T, Xiaojuan S, Long G, Yi Q, et al. Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis. Ann Med. 2020;52(7):376\u201385.","journal-title":"Ann Med"},{"issue":"3","key":"771_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","volume":"74","author":"E-J Won","year":"2017","unstructured":"Won E-J, Choi J-H, Cho Y-N, Jin H-M, Kee HJ, Park Y-W, et al. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease. J Infect. 2017;74(3):281\u201393.","journal-title":"J Infect"},{"key":"771_CR27","doi-asserted-by":"crossref","unstructured":"Rapulana AM, Mpotje T, Baiyegunhi OO, Ndlovu H, Smit TK, McHugh TD, et al. Combined analysis of host IFN-\u03b3, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6\/CFP-10 stimulated\u00a0blood. Front Mol Med. 2024;4:1345510.","DOI":"10.3389\/fmmed.2024.1345510"},{"issue":"8","key":"771_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","volume":"16","author":"R Biselli","year":"2010","unstructured":"Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, et al. Detection of interleukin-2 in addition to interferon-\u03b3 discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect. 2010;16(8):1282\u20134.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"771_CR29","doi-asserted-by":"publisher","first-page":"e0146098","DOI":"10.1371\/journal.pone.0146098","volume":"11","author":"IA Biraro","year":"2016","unstructured":"Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, et al. The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda. PLoS ONE. 2016;11(1):e0146098.","journal-title":"PLoS ONE"},{"key":"771_CR30","doi-asserted-by":"crossref","unstructured":"Ssekamatte P, Nakibuule M, Nabatanzi R, Egesa M, Musubika C, Bbuye M et al. Type 2 diabetes mellitus and latent tuberculosis infection moderately influence innate lymphoid cell immune responses in Uganda. Front Immunol. 2021;12(3551):71681938.","DOI":"10.3389\/fimmu.2021.716819"},{"issue":"7","key":"771_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"771_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(1):77.","journal-title":"BMC Bioinformatics"},{"key":"771_CR33","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. 2 ed. Springer Cham; 2016. p. 260."},{"issue":"1","key":"771_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1084\/jem.186.1.39","volume":"186","author":"AM Cooper","year":"1997","unstructured":"Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med. 1997;186(1):39\u201345.","journal-title":"J Exp Med"},{"issue":"1","key":"771_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jmii.2014.11.019","volume":"50","author":"Y-Y Chen","year":"2017","unstructured":"Chen Y-Y, Lin C-W, Huang W-F, Chang J-R, Su I-J, Hsu C-H, et al. Recombinant Bacille Calmette\u2013Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. J Microbiol Immunol Infect. 2017;50(1):90\u20136.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"771_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4049\/jimmunol.2400145","volume":"213","author":"K Maciag","year":"2024","unstructured":"Maciag K, Plumlee CR, Cohen SB, Gern BH, Urdahl KB. Reappraising the role of T Cell\u2013Derived IFN-\u03b3 in restriction of Mycobacterium tuberculosis in the murine lung. J Immunol. 2024;213(3):339\u201346.","journal-title":"J Immunol"},{"issue":"1","key":"771_CR37","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/srep01809","volume":"3","author":"N Allie","year":"2013","unstructured":"Allie N, Grivennikov SI, Keeton R, Hsu N-J, Bourigault M-L, Court N, et al. Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci Rep. 2013;3(1):1809.","journal-title":"Sci Rep"},{"issue":"2","key":"771_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2008.06.011","volume":"29","author":"H Clay","year":"2008","unstructured":"Clay H, Volkman HE, Ramakrishnan L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity. 2008;29(2):283\u201394.","journal-title":"Immunity"},{"key":"771_CR39","doi-asserted-by":"crossref","unstructured":"Blauenfeldt T, Petrone L, del Nonno F, Baiocchini A, Falasca L, Chiacchio T et al. Interplay of DDP4 and IP-10 as a potential mechanism for cell recruitment to tuberculosis lesions. Front Immunol. 2018;9:0145639.","DOI":"10.3389\/fimmu.2018.01456"},{"key":"771_CR40","doi-asserted-by":"crossref","unstructured":"Krupa A, Fol M, Dziadek BR, Kepka E, Wojciechowska D, Brzostek A et al. Binding of CXCL8\/IL-8 to Mycobacterium tuberculosis modulates the innate immune response. Mediators of inflammation. 2015;2015:124762.","DOI":"10.1155\/2015\/124762"},{"key":"771_CR41","doi-asserted-by":"crossref","unstructured":"Morelli MP, Martin C, Pellegrini JM, Blanco F, Bigi F, Ciallella L, et al. Neutrophils from tuberculosis patients are polarized toward pro-inflammatory and anti-inflammatory phenotypes according to the disease severity. J Immunol. 2025;214(6):1173\u201386.","DOI":"10.1093\/jimmun\/vkaf010"},{"issue":"2","key":"771_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.tube.2009.01.001","volume":"89","author":"DM Higgins","year":"2009","unstructured":"Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Lee EJ, Orme IM, Gonzalez-Juarrero M. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis. 2009;89(2):149\u201357.","journal-title":"Tuberculosis"},{"issue":"10","key":"771_CR43","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/infdis\/jiu329","volume":"210","author":"NP Kumar","year":"2014","unstructured":"Kumar NP, George PJ, Kumaran P, Dolla CK, Nutman TB, Babu S. Diminished systemic and Antigen-Specific type 1, type 17, and other Proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection. J Infect Dis. 2014;210(10):1670\u20138.","journal-title":"J Infect Dis"},{"key":"771_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tube.2017.11.008","volume":"108","author":"X Wang","year":"2018","unstructured":"Wang X, Wu Y, Jiao J, Huang Q. Mycobacterium tuberculosis infection induces IL-10 gene expression by disturbing histone deacetylase 6 and histonedeacetylase 11 equilibrium in macrophages. Tuberculosis. 2018;108:118\u201323.","journal-title":"Tuberculosis"},{"key":"771_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","volume":"34","author":"SK Mittal","year":"2015","unstructured":"Mittal SK, Roche PA. Suppression of antigen presentation by IL-10. Curr Opin Immunol. 2015;34:22\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"771_CR46","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","volume":"187","author":"CL Day","year":"2011","unstructured":"Day CL, Abrahams DA, Lerumo L, van Janse E, Stone L, O\u2019rie T, et al. Functional capacity of Mycobacterium tuberculosis-Specific T cell responses in humans is associated with mycobacterial load. J Immunol. 2011;187(5):2222\u201332.","journal-title":"J Immunol"},{"issue":"8","key":"771_CR47","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.4049\/jimmunol.178.8.5217","volume":"178","author":"KA Millington","year":"2007","unstructured":"Millington KA, Innes JA, Hackforth S, Hinks TSC, Deeks JJ, Dosanjh DPS, et al. Dynamic relationship between IFN-\u03b3 and IL-2 profile of Mycobacterium tuberculosis-Specific T cells and antigen load. J Immunol. 2007;178(8):5217\u201326.","journal-title":"J Immunol"},{"issue":"13","key":"771_CR48","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","volume":"18","author":"MA Sallin","year":"2017","unstructured":"Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, Barber DL. Th1 differentiation drives the accumulation of Intravascular, Non-protective CD4 T cells during tuberculosis. Cell Rep. 2017;18(13):3091\u2013104.","journal-title":"Cell Rep"},{"issue":"1","key":"771_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12874-015-0085-z","volume":"15","author":"T Xu","year":"2015","unstructured":"Xu T, Fang Y, Rong A, Wang J. Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy. BMC Med Res Methodol. 2015;15(1):94.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"771_CR50","doi-asserted-by":"publisher","first-page":"e41836","DOI":"10.1016\/j.heliyon.2025.e41836","volume":"11","author":"KH Hoang Nguyen","year":"2025","unstructured":"Hoang Nguyen KH, Le NV, Nguyen PH, Nguyen HHT, Hoang DM, Huynh CD. Human immune system: exploring diversity across individuals and populations. Heliyon. 2025;11(2):e41836.","journal-title":"Heliyon"},{"issue":"5","key":"771_CR51","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/s41591-025-03602-0","volume":"31","author":"GS Temba","year":"2025","unstructured":"Temba GS, Pecht T, Kullaya VI, Vadaq N, Mosha MV, Ulas T, et al. Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial. Nat Med. 2025;31(5):1698\u2013711.","journal-title":"Nat Med"},{"issue":"9","key":"771_CR52","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.immuni.2024.07.021","volume":"57","author":"SJ Sun","year":"2024","unstructured":"Sun SJ, Aguirre-Gamboa R, de Bree LCJ, Sanz J, Dumaine A, van der Velden WJFM, et al. BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses. Immunity. 2024;57(9):2095\u2013e1078.","journal-title":"Immunity"},{"key":"771_CR53","unstructured":"MoH. Uganda population-based HIV impact assessment Uphia 2020\u20132021. Ministry of Health (MOH) Uganda: Kamapala, Uganda. 2022."},{"key":"771_CR54","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: WHO; 2024."},{"key":"771_CR55","doi-asserted-by":"crossref","unstructured":"Kyazze AP, Ssekamatte P, Nakavuma R, Emoru R, Laizer SN, Mrema LE, et al. OA-359\u00a0Latent tuberculosis infection among people with diabetes mellitus in Uganda and Tanzania. BMJ\u00a0Glob Health. 2023;8(Suppl 10):A13\u2013A4.","DOI":"10.1136\/bmjgh-2023-EDC.31"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00771-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00771-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00771-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:51:32Z","timestamp":1762519892000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00771-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00771-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants and\/or their legal guardian(s) before enrolment in the Tuberculosis and Diabetes (TAD) study. The TAD study was approved by the School of Biomedical Sciences Research and Ethics Committee (SBS-REC), Makerere University (reference number: SBS-398), and the Uganda National Council for Science and Technology (UNCST) (reference number: HS66ES). Ethical approval for this nested study was granted by SBS-REC, reference number SBS-2021-41, and UNCST, reference number HS1696ES. The methods that support these results were performed in accordance with relevant guidelines and regulations, and all data were anonymised. This study was conducted in accordance with the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}